Cowen Starts Liquidia Technologies (LQDA) at Outperform

Cowen analyst Ken Cacciatore initiates coverage on Liquidia Technologies (NASDAQ: LQDA) with a Outperform rating and a price target of $40.00.

The analyst comments "The lead asset is LIQ861 for PAH, an inhaled reformulation of a known active molecule, treprostinil, that is more optimally designed and should rapidly transition, convert and expand a current $400MM target market. We would add."

For an analyst ratings summary and ratings history on Liquidia Technologies click here. For more ratings news on Liquidia Technologies click here.

Shares of Liquidia Technologies closed at $14.90 yesterday.

You May Also Be Interested In

• BofA Securities Resumes Williams-Sonoma (WSM) at Buy
• Adobe (ADBE) PT Lowered to $250 at DA Davidson
• Piper Sandler Assumes Fulton Financial (FULT) at Neutral